Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination therapy containing **xiyanping**, **mannitol**, **methylprednisolone**, and **immunoglobulin**, used for intensive anti-inflammatory, immunomodulatory, antiviral, and supportive purposes. - **Xiyanping** is a semi-synthetic injectable preparation from *Andrographis paniculata* mainly used in China, with active components including andrographolide sulfates. It is traditionally used for its antiviral, antibacterial, anti-inflammatory, and antitoxic effects, often in the treatment of upper respiratory tract infections, viral pneumonia, and as adjuvant therapy in COVID-19[3][5][1][9][7]. - **Mannitol** is an osmotic diuretic commonly used to reduce intracranial and intraocular pressure and as a renal function diagnostic aid. - **Methylprednisolone** is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties, indicated for a broad range of autoimmune, allergic, and inflammatory disorders[2][4][6][8][10]. - **Immunoglobulin (IVIG)** is typically used for immune modulation and as replacement therapy in immune deficiencies or certain autoimmune diseases. This combination is likely employed in severe infections or immune-mediated disease states requiring management of inflammation, edema, immunosuppression, and immune support, though it does not represent a single registered product with a unique brand or formulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiyanping + mannitol + methylprednisolone + immunoglobulin.